Neurocava-Peji Capsule 150mg (Pregabalin)

Adult dose

This medication, which contains pregabalin, is administered orally without regard to food, with a total daily dosage divided into two doses. 1. Neuropathic pain - Peripheral neuropathic pain: The starting dose is 150 mg once daily, which can be increased to 300 mg after 3 to 7 days. If necessary, it can be increased to the maximum daily dose of 600 mg at 7-day intervals. - Central neuropathic pain: Starting dose is 150 mg once daily.

Child dose

Safety and efficacy data are insufficient for pediatric patients under 12 years of age and adolescents aged 12 to 17, so administration is not recommended.

This drug may increase the risk of suicidal thoughts or actions, so if any symptoms of depression or mood changes occur while taking this medication, consult a doctor immediately. Those with an allergy to pregabalin or any components of this medication should not take it. Diabetic patients may be affected by blood sugar control due to weight gain, so dosage adjustments for hypoglycemic medications may be necessary. If symptoms of angioedema appear, discontinue use immediately and inform your doctor. Elderly patients should be cautious of fall risks due to dizziness or drowsiness, particularly when starting the medication. Temporary blurred vision or changes in eyesight can occur, and if such symptoms arise, consult your doctor. Abrupt discontinuation of this medication may result in withdrawal symptoms such as insomnia, headache, and anxiety, so dosage should be gradually reduced according to your doctor's instructions. Patients with a history of substance abuse are at higher risk of misuse of this drug and should take it with extra caution. Dose adjustments may be required for patients with decreased kidney function. Patients with heart disease should be cautious when using this medication. Caution is advised when taking it with opioid analgesics as it may increase the risk of central nervous system depression. Patients with respiratory diseases or kidney impairment, as well as elderly individuals, may have a higher risk of severe respiratory depression, and dose adjustments may be necessary. Pregnant women should avoid taking this medication in early pregnancy due to the risk of fetal malformations, and women of childbearing age should use effective contraception. If breastfeeding, consult with your doctor as this medication can be transferred through breast milk and affect the baby. Caution is advised when driving or operating machinery due to the risk of accidents from dizziness or drowsiness until the symptoms have completely resolved. Rarely, severe skin adverse reactions can occur, so discontinue use and inform medical personnel if a rash or redness develops. Overdose may cause confusion, drowsiness, and seizures, which require immediate emergency treatment. Keep this medication out of reach of children, and do not transfer it to other containers.

Serious side effects

Hives, severe swelling (including angioedema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, skin peeling, oral/ocular mucosal pain, difficulty breathing or shortness of breath, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, lightning headache, seizures, confusion, visual disturbances, coma

Mild side effects

• Dizziness
• drowsiness
• confusion
• disturbance in spatial awareness
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication can be sensitive to air and moisture, so it must be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 15°C and 30°C.

Appearance

A hard capsule with a white upper part and a white lower part containing a white to pale yellow powder.

Package unit

For domestic use - 30 capsules/bottle, For domestic use - 100 capsules/bottle, For export - 30 capsules/box[((10 tablets/PTP)*3)]